Subscribe
Subscribe today to receive CGD’s latest newsletters and topic updates.
All Commentary
Filters:
Topics
Facet Toggle
Content Type
Facet Toggle
Blog Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
September 05, 2023
Today the Africa Centers for Disease Control’s (ACDC) Health Economics Programme (HEP) has published a new policy brief on the cost-effectiveness of two COVID-19 oral antivirals (COAVs), a nirmatrelvir/ritonavir combination, developed by Pfizer and sold under the name Paxlovid, and Molnupiravir, dev...
Blog Post
August 22, 2023
A recent, thought-provoking blog by our colleague, Justin Sandefur, titled “How Economists got Africa’s AIDS Epidemic Wrong”, has sparked a debate about the historical role of cost-effectiveness analysis in assessing the investments of the President's Emergency Plan for AIDS Relief (PEPFAR) and, imp...
Blog Post
July 06, 2023
Calls for MDB reform have emerged in recent years, including at COP27 and by G20 leaders. These have largely focused on scaling up the amount of funding available. What’s really needed is a paradigm shift: MDBs must evolve both in the work they do and the way they operate to meet the world’s urgent ...
Blog Post
June 01, 2023
No longer the new kid on the block, Effective Altruism (EA) has evolved from its early days in the quadrangles of the University of Oxford to become a thriving community with a well-established architecture of philanthropic institutions. EA organisations now marshal resources in the hundreds of mill...
Blog Post
April 25, 2023
MDBs and DFIs know how to originate assets in markets that other investors are unable to reach. Some have also learnt how to package and share these assets with institutional investors. It's time they focused these capacities on scaling up their mobilization of private capital in areas where there i...